WIA
PRQR icon

Wetzel Investment Advisors’s ProQR Therapeutics PRQR Stock Holding History

Wetzel Investment Advisors’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.5K Buy
+10,500
New +$17.3K 0.01% 139

Other funds holding PRQR

FSA
Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
MLL
Moody Lynn & Lieberson Boston, Massachusetts $1.9B AUM 27.82% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
PP
PFS Partners Mine Hill, New Jersey $247M AUM 29.02% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Wetzel Investment Advisors's PRQR Position: Q2 2026 in Review

Wetzel Investment Advisors opened a new position in ProQR Therapeutics (PRQR) in Q2 2026: 10,500 shares worth $19.5K. The stake represents 0.01% of the portfolio and ranks #139 among its holdings.

8 funds tracked by Wall St. Rank hold PRQR as of Q2 2026.

  • Wetzel Investment Advisors held 10,500 shares of ProQR Therapeutics worth $19.5K as of Q2 2026.
  • ProQR Therapeutics was a new Wetzel Investment Advisors position in Q2 2026.
  • ProQR Therapeutics made up 0.01% of Wetzel Investment Advisors's portfolio in Q2 2026, its #139 holding.
  • 8 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q2 2026.

Based on Wetzel Investment Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.